Common bile duct (CBD) stones are a common hepatobiliary condition all around the world [1]. Along with the rapid development of endoscopic technology, endoscopic treatments have become an attractive therapy for the removal of CBD stones rather than traditional surgical treatment because endoscopic treatments are less invasive and lead to fewer complications [2] . Currently, two common types of endoscopic treatments are widely used for CBD stone removal in clinical practice, namely, endoscopic sphincterotomy (EST) and endoscopic papillary balloon dilation (EPBD) [3] .
To overcome the limitations of EST alone and EPBD alone, endoscopic sphincterotomy plus endoscopic papillary balloon dilation (ESBD) was first introduced for CBD stone removal in 2003 [10] . Subsequent studies have shown that ESBD has efficient stone clearance and acceptable adverse events [11] . However, compared with EST alone, it is still unclear which procedure is better, especially for the removal of large CBD stones. The evidence provided by existing studies is weak and remains controversial: some studies report that ESBD has similar efficacy and safety to EST [12] , whereas others report that ESBD is superior to EST for the removal of large CBD stones [13] . For this reason, we searched all published studies on this topic in electronic databases, including PubMed, EMBASE, and the Cochrane Library, and performed a meta-analysis to compare the efficacy and safety of ESBD vs. EST for the removal of large CBD stones. Moreover, we also compared the need for mechanical lithotripsy and total procedure time between ESBD and EST groups for CBD stone removal.
Methods

Literature search strategy
Published literature was searched through electronic databases including PubMed, EMBASE, and the Cochrane Library, through to 15 July 2018. The following keywords were used for the search: "endoscopic sphincterotomy," "balloon dilation," and "choledocholithiasis" or "common bile duct stone." Additionally, related or similar articles provided by the databases, as well as citations from pertinent articles, were also considered in order to broaden the search. Authors were contacted through emails to obtain unpublished data. The literature search was conducted independently by two reviewers (S.Q.D. and T.P.S.), and a final confirmation was made by another reviewer (H.L. W.).
Study selection criteria
Inclusion criteria were: 1) clinical trials comparing ESBD vs. EST for the removal of CBD stones -both RCTs and nonrandomized comparative trials (NRCTs) were considered; 2) trials enrolling patients with large stones (diameter of the largest stone ≥ 10 mm) or multiple stones; 3) trials confirming CBD stones, stone size, stone number, and stone removal by endoscopic retrograde cholangiopancreatography (ERCP) or endoscopic ultrasound; 4) trials using standard methods (according to the 1991 consensus guidelines [14] ) to define early complications and to record them in detail; and 5) trials not limited in ethnicity and language.
Exclusion criteria were: 1) case reports; 2) systematic reviews or meta-analyses comparing ESBD vs. EPBD or EST vs. EPBD; 2) individual trials focusing on comparing ESBD vs. EPBD or EST vs. EPBD; 3) trials focusing on ESBD or EST or EPBD alone; 4) trials focusing on other diseases, such as pancreatic diseases; and 5) unavailability of the full article.
Study quality assessment
After selection of studies, the quality of eligible trials was assessed. RCTs were assessed according to the risk of bias using the Cochrane reviewer's handbook (Version 5.1.0). The following items were assessed: 1) methods of random allocation generation and allocation concealment; 2) blinding of participants and researchers; 3) blinding of the outcome assessors; 4) selective outcome reporting; 5) attrition bias; and 6) other biases. NRCTs were assessed according to the Newcastle-Ottawa Scale for case -control studies. The following items were assessed: 1) definition of cases; 2) representativeness of cases; 3) selection of controls; 4) definition of controls; 5) comparability of cases and controls; 6) determination of exposure factor; 7) whether the same method had been used to determine exposure factor between case and control groups; and 8) nonresponse rate of the two groups. NRCTs with total points ≥ 5 were included.
Data extraction
Data regarding the following main outcomes were extracted from each study: 1) total stone removal rate; 2) stone removal rate during the first ERCP session; 3) rate of procedure-related complications; 4) frequency of mechanical lithotripsy used; and 5) procedure time. Tables, figures, supplemental materials, and notes on the studies were used for data extraction. Data extraction was performed independently by two reviewers (Q.Z. was responsible for RCT data extraction and J.J.L. was responsible for NRCT data extraction), and final confirmations were made by another reviewer (H.L.W.).
Statistical analysis
Review Manager (Version 5.3) was used for the statistical analyses of the meta-analysis. We used a pooled odds ratio (OR) and 95 % confidence interval (CI) to analyze most outcomes, with the exception of the procedure time, which was analyzed by using pooled mean difference and 95 %CI. The chi-squared test and Higgins I 2 statistic were used to estimate the heterogeneity among different studies. Heterogeneity was not considered to be significant among the included studies when P > 0.1 and I 2 < 50 %, and the fixed effects model was used in those instances. Otherwise, heterogeneity was considered to exist and a random effects model was used. Owing to the differences in study type between RCTs and NRCTs, the data from both subgroups could be pooled only if there was not significant heterogeneity. In all analyses, P < 0.05 was considered statistically significant. Additionally, funnel plots and Egger's tests were used to evaluate the publication bias; P ≥ 0.1 was considered to indicate no significant publication bias. Sensitivity analysis was also conducted to confirm the stability of our results.
included [12, 13, 15 -30] [26] ). The detailed selection process is shown in Fig. 1s ESBD, endoscopic sphincterotomy plus endoscopic papillary balloon dilation; EST, endoscopic sphincterotomy; NR, not reported; NRCT, nonrandomized comparative trial; RCT, randomized controlled trial. 1 The diameter of the largest stone. 2 Number of sessions reported. 3 Mean value. 4 % of patients with > 1 stone. 5 % of patients with ≥ 3 stones. 6 Multiple stones.
According to the Cochrane reviewer's handbook, most RCTs were of moderate quality and only one was of high quality (Fig.  2s) . The main reasons affecting the quality of RCTs were: 1) blinding of participants and researchers was not designed or mentioned; 2) blinding of the outcome assessors was not designed or mentioned; 3) most studies included data from only one clinical center with a small sample size, which may cause a high selection bias; 4) follow-up information of most RCTs was unclear or trials did not record follow-up details. However, most NRCTs included were of moderate-to-high quality, with total points ranging from 5 to 8 according to the Newcastle-Ottawa Scale (Table 1s) .
Efficacy
We first compared the total stone removal rate between the ESBD group and the EST group. In total, 17 studies were included, containing 8 RCTs [12, 15 -21] and 9 NRCTs [22 -30] . One RCT [13] was excluded because it had a procedure crossover after failure by EST alone. As shown in ▶ Fig. 1a , the crude total stone removal rate was 97.4 % (95 %CI 95.6 % to 99.0 %) in the ESBD group and 93.5 % (95 %CI 87.7 % to 95.8 %) in the EST group, and the total pooled OR (2.68, 95 %CI 1.79 to 4.01) indicated that the efficacy of ESBD was superior to that of EST alone, with no significant heterogeneity (P = 0.47, I 2 = 0 %). Ad- Next, we compared the rate of stone removal during the first ERCP session. A total of 15 studies were included, containing 7 RCTs [12, 13, 15, 16, 18, 20, 21 ] and 8 NRCTs [22, 23, 25 -30] . Three studies [17, 19, 24] were excluded because they did not report the data on the outcome. As shown in ▶ Fig. 1b , our meta-analysis revealed that the crude rate of stone removal during the first ERCP session was 88.1 % (95 %CI 84.9 % to 91.5 %) in the ESBD group and 79.4 % (95 %CI 71.8 % to 84.0 %) in the EST group. The results indicated that ESBD was significantly superior to EST (pooled OR 2.07, 95 %CI 1.37 to 3.12) for CBD stone removal during the first ERCP session. Additionally, the pooled OR of the RCT subgroup (2.05, 95 %CI 1.10 to 3.81) was consistent with that of the NRCT subgroup (2.10, 95 %CI 1.17 to 3.77), and there was no significant heterogeneity between the two subgroups (P = 0.95, I 2 = 0 %).
Several subgroup analyses were conducted to investigate the influence of stone size, stone number, and method of EST performed in the ESBD group on the stone removal rate. The results indicated that the efficacy of ESBD was significantly superior to that of EST in patients with a stone size ≥ 10 mm (pooled OR 3.19, 95 %CI 1.73 to 5.88) or in patients with stone numbers ≥ 3 (pooled OR 5.23, 95 %CI 1.20 to 22.72). However, ESBD only had a tendency to be superior to EST in patients with a stone size ≥ 15 mm, without statistical significance (pooled OR 2.07; 95 %CI 0.94 to 4.57). Moreover, the efficacy of small incisions (limited to one-third of the diameter of the papilla) in the ESBD group appeared to be superior to EST alone (pooled OR 2.35, 95 %CI 1.24 to 4.46), as shown in Fig. 3s .
Safety
In total, 16 studies [12, 13, 15 -17, 20 -30] were used to compare the rate of early complications between ESBD and EST groups. As shown in ▶ Fig. 2 , the results of our meta-analysis showed that the ESBD group had a lower rate of early complications compared with the EST group (total pooled OR 0.63, 95%CI 0.47 to 0.85), with no significant heterogeneity (P = 0.89, I 2 = 0 %). Additionally, the trends of pooled ORs of the RCT subgroup (0.61, 95 %CI 0.39 to 0.93) and the NRCT subgroup (0.66, 95 %CI 0.43 to 1.00) seemed similar, with no significant heterogeneity between the two subgroups (P = 0.80, I 2 = 0 %). Tau To further compare the differences in complication rates, we analyzed four common complications, including pancreatitis, significant bleeding, acute cholangitis, and perforation. The results showed no significant differences between the two groups in the rates of these complications, except for the rate of significant bleeding, which was lower in the ESBD group compared with the EST group (pooled OR 0.35, 95 %CI 0.17 to 0.73), as shown in Table 2s .
ESBD
Mechanical lithotripsy use
A total of 15 studies [12, 13, 15, 16, 18, 20 -24, 26 -30] were included to assess the frequency of mechanical lithotripsy during the procedures. As shown in ▶ Fig. 3 , mechanical lithotripsy was used less frequently in the ESBD group compared with the EST group (pooled OR 0.38, 95 %CI 0.24 to 0.61) by using a random effects model (P < 0.001, 
Procedure time
Seven studies [12, 15, 18, 20 -22, 28] contained adequate information from which to compare the procedure times between ESBD and EST groups. As shown in ▶ Fig. 4 , although trends in the RCT subgroup showed that there was no significant difference between the two groups (pooled mean difference -3.07, 95 %CI -6.70 to 0.56), the results of the NRCT subgroup (pooled mean difference -6.41, 95 %CI -9.70 to -3.12]) and the total pooled mean difference (-4.05, 95 %CI -7.02 to -1.09) showed that the ESBD group had a shorter procedure time than the EST group, with a low level of heterogeneity (P = 0.18, I 2 = 43.8 %). 
ESBD
Discussion
This meta-analysis compared the efficacy of ESBD vs. EST for the removal of large CBD stones. Several meta-analyses have previously been published on this topic [9, 31 -33] . Most of them concluded that ESBD had a similar efficacy to EST [31 -33] . However, a newly published study concluded that ESBD was numerically superior to EST, without statistical differences [9] . Herein, we confirmed the superiority of ESBD, with significantly statistical differences in both the RCT and the NRCT subgroups, by including more RCTs and including NRCTs for the first time. The total pooled OR also validated the superiority of ESBD without significant heterogeneity. Moreover, we found that the superiority of ESBD was more significant during the first session of ERCP compared with EST alone. All results indicated that it is much easier to successfully remove large CBD stones by using ESBD. Additionally, funnel plots (see Fig. 4s ) and Egger's tests (Table 3s ) confirmed that there was no significant publication bias for our results, and the sensitivity analyses show that all the results were stable (Table 4s) .
Next, we compared the total rate of early complications. The results showed that ESBD had fewer early complications compared with EST. Our conclusion differed slightly from previously published meta-analyses, which reported that ESBD is as safe as EST [31, 32] . For this reason, we further compared the rates of four common early complications by conducting subgroup analyses. The results indicated that there was no significant difference between the two groups for the rates of pancreatitis, acute cholangitis, and perforation. However, the rate of significant bleeding was lower in the ESBD group than in the EST group. This result was comparable to another newly published meta-analysis [33] . As has been reported by several studies [34, 35] , less bleeding might be explained by the fact that EPBD used during the ESBD procedure may have had a protective effect on the function of the papillary muscle.
Finally, we compared the frequency of mechanical lithotripsy use and the procedure time between the ESBD group and the EST group. The results showed that the ESBD group required less mechanical lithotripsy and a shorter procedure time than the EST group. This conclusion differs from previously published meta-analyses, which indicated that no significant difference was found between the two groups when comparing mechanical lithotripsy use and procedure time [9, 32] . The most reasonable explanation for the difference may be that more studies and more patients were included in our meta-analysis. However, significant heterogeneity existed in some of our results, such as the comparison of mechanical lithotripsy use. We investigated the causes of heterogeneity and found that the major factor was a difference in CBD stone characteristics, especially stone size and stone number. For this reason, we performed subgroup analyses to clarify the influence of stone characteristics on our results. For stone size comparison, the results showed that the efficacy of ESBD was superior to that of EST in patients with stone sizes ≥ 10 mm, but it only tended to be better than EST without significantly statistical difference when the stone size was ≥ 15 mm. For comparison of stone number, the results indicated that the efficacy of ESBD was significantly superior to EST for patients with ≥ 3 stones. However, the number of studies included for the subgroup analyses were inadequate and more studies are still needed in the future to confirm our conclusions.
Additionally, the method of sphincterotomy used in the ESBD group was also a possible confounding factor affecting the results of our meta-analysis. We conducted a subgroup analysis of patients with incisions limited to one-third of the diameter of the duodenal papilla. The results showed that the efficacy of ESBD was better than that of EST alone, which indicated that a minor incision may be adequate for the removal of large CBD stones by using ESBD. Indeed, the balloon size and dilation time used in ESBD could also influence the results. However, subgroup analyses could not be conducted because detailed information about balloon size and dilation time used in the ESBD group were unclear or missing (as shown in ▶ Table 1). For this reason, it would be better to choose a balloon size and dilation time according to the largest stone size, and a balloon with a 12 -20 mm diameter for a dilation time of 30 -60 seconds will usually be adequate [36] .
In conclusion, the efficacy of ESBD was superior to that of EST for the removal of large CBD stones, both during the first ERCP session and across all ERCP sessions. Less mechanical lithotripsy was needed and the procedure time was shorter when ESBD was used to remove large CBD stones. Moreover, ESBD was safer than EST for large CBD stone removal and in particular may reduce the occurrence of significant bleeding. However, additional well-designed, multicenter RCTs with large sample sizes are still needed in future to confirm the superiority of ESBD.
